SEC Tracker
Get the app

Response Biomedical

Response Biomedical FY 2011: net loss $5.4M

Form
10-K/A
Filed
Period
Importance
Routine
Document
10-K/A

Key figures from this report

These are the numbers Response Biomedical reported for the year ended Dec 31, 2011, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$5.4MNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Cash and cash equivalents$7.4MNo year-earlier figure tagged10-K balance sheet, on EDGAR
  3. Cash from operations−$2.6MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

View on EDGAR

Open in the app

Get an email when Response Biomedical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.